Dr Anna Kalff
Dr Anna Kalff is a dual trained haematologist at The Alfred and Cabrini, and a clinician-researcher within the Myeloma Research Group (MRG), Monash University.
Dr Kalff's research has been published in peer review journals and presented at both national and international meetings. She has received awards from the American Society of Haematology (ASH), International Myeloma Society (IMS), Myeloma Australia (MFA) and Haematology Society of Australia and New Zealand (HSANZ).
Dr Kalff is a member of the myeloma/lymphoma craft groups at the Alfred where her clinical role involves the care of both outpatient and inpatients (including patients undergoing CAR-T, T-cell engaging (TCE) therapy and autologous stem cell transplant). She is an investigator for numerous investigator-initiated and sponsored myeloma clinical trials (including CAR-T and TCE therapies) as well as CAR-T trials in auto-immune disease. Dr Kalff is also a member of the Myeloma Australia Medical Scientific Advisory Group (MSAG), The ALLG myeloma working party and on the Snowdome Foundation Grants Committee.